Corrected-Merck KGaA says avelumab alliance with Pfizer on track By: Reuters: Company News October 01, 2015 at 09:20 AM EDT * Says it started investigating a novel, potential first-in- class bi-functional immunotherapy in clinical trials Read More >> Related Stocks: Merck & Co Pfizer